Clinical Trial: A Clinical Study to Evaluate the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects With Impaired Liver Function Versus Normal Liver Function

U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07538973) titled 'A Clinical Study to Evaluate the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects With Impaired Liver Function Versus Normal Liver Function' on April 13.

Brief Summary: Evaluation of the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects with Impaired Liver Function versus Normal Liver Function

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Lung Cancer

Intervention: DRUG: Anecatibin Fumarate Capsules

Anecatibin fumarate capsule is a prodrug that can be rapidly hydrolyzed into crizotinib in vivo to exert pharmacodynamic effects. Crizotinib is a tyrosine kinase r...